Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Activation of PPARy2 by Rosiglitazone Causes Bone Loss Associated with Increased Marrow Adiposity and Decreased Osteoblast Number in Mice

Jilka RL, Lecka-Czernik B, Ali AA, O'Brien CE, Weinstein RS, Manolagas SC. Activation of PPARy2 by Rosiglitazone Causes Bone Loss Associated with Increased Marrow Adiposity and Decreased Osteoblast Number in Mice. J Bone Miner Res 16(supple 1):S319. 2001.


collapse authors with profiles